Frost.com - Healthcare and Life Sciences IT Researchhttp://www.frost.com/prod/servlet/svcg.pag/HCHL
http://www.frost.com/prod/servlet/svcg.pag/HCHL
- Healthcare and Life Sciences IT ResearchFrost & SullivanAn Integrator to Help Address the Grand Challenge of Health System Change: Frost & Sullivan Movers & Shakers Interview with Daniel S. Pelino, General Manager, Global Healthcare and Life Sciences, IBM Corporationhttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=252840000
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=252840000
Mon, 6 Feb 2012 00:00:00 +0000Genetic Technology Alert. Cell-Free Expression System for Scalable Production of Protein Therapeutics; Drug and Vaccine Delivery Platform Based on Stomach Bacteria; Plant-Derived Protein Therapeutics To Lower Healthcare Costshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-81-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-81-00-00
This issue profiles plant-derived protein therapeutics for lowering healthcare costs, a cell-free expression system for scalable production of protein therapeutics, and a drug and vaccine delivery platform based on stomach bacteria. Strategic partnership details and some important patents have also been included.Fri, 3 Feb 2012 05:39:03 +0000Futuretech Alert. Optogeneticshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D833-00-CC-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D833-00-CC-00-00
This Future Tech Alert profiles developments in optogenetics, which is an emerging genetic discipline for studying cell function.Fri, 3 Feb 2012 02:21:02 +0000Genetic Technology Alert. Enhancing Microbe Detection and Identification; Tobacco Plant Cell-Based Protein Expression Platform for Biosimilars; Approaching Hepatitis C Therapies through Monocistronic Reporter Viruseshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-80-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-80-00-00
This issue profiles enhancing microbe detection and identification, a tobacco plant cell-based protein expression platform for biosimilars, and approaching hepatitis C therapies through monocistronic reporter viruses. Strategic partnership details and some important patents have also been included.Fri, 27 Jan 2012 23:12:31 +0000Medical Device Technology Alert. Paper-Based Diagnostic Test Targeting Influenza; Heart Monitoring Device for Tracking Sudden Cardiac Arrest; Device Implantation Challenges Addressed by Using Bio-Based Coatingshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D851-00-0A-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D851-00-0A-00-00
This issue profiled a paper-based diagnostic test for influenza, heart monitoring device for tracking sudden cardiac arrest, and device implantation challenges addressed by using bio-based coatings.Fri, 20 Jan 2012 06:40:31 +0000Genetic Technology Alert. Simultaneous Study of Chromatin and DNA Methylation in a Microplate Platform; Improving Cancer Diagnostics and Therapeutics through Epigenetic Applications; Plant Cell Expression-Based Protein Therapeuticshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7F-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7F-00-00
This issue profiles a simultaneous study of chromatin and DNA methylation in a microplate platform, improving cancer diagnostics and therapeutics through epigenetic applications, and plant cell expression-based protein therapeutics. Strategic partnership details and some important patents have also been included.Fri, 20 Jan 2012 02:39:30 +0000Genetic Technology Alert. Microarray Platform for Orphan Receptors and Ligands; Ligosachharide-Based Test for Diagnosis and Prognosis of MPS; Antibody Generating Platform Based on Somatic Hypermutationhttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7E-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7E-00-00
This issue profiles a microarray platform for orphan receptors and ligands, a ligosachharide-based test for diagnosis and prognosis of MPS, and an antibody generating platform based on somatic hypermutation. Strategic partnership details and some important patents have also been included.Fri, 13 Jan 2012 04:37:30 +0000Inside R&D Alert. Drug Delivery Systems for Regenerative Medicine; Electron Model for Enhancing Particle Therapy for Cancer; New Sensor Technology for Detecting Deterioration of Telecommunication Cableshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6C-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6C-00-00
This issue profiles drug delivery systems for regenerative medicine, an electron model for enhancing particle therapy for cancer, and a new sensor technology for detecting deterioration of telecommunication cables.Fri, 13 Jan 2012 01:21:31 +0000Genetic Technology Alert. RNA-Based Expression System for Vaccine Development; Combination of Multiplexed PCR and Ion Semiconductor Sequencing Accelerates Cancer Research; Using Virus-Like Particles for Counteracting against Emerging Pathogenshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7D-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7D-00-00
This issue profiles an RNA-based expression system for vaccine development, a gene array that aids in diagnosis of anti-EGFR responsive mCRC, and using virus-like particles for counteracting against emerging pathogens. Strategic partnership details and some important patents have also been included.Fri, 6 Jan 2012 03:10:30 +0000Growth Trends of Multiple Sclerosis Therapeuticshttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=250608955
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=250608955
Multiple Sclerosis (MS) can be classified as a neurodegenerative, immune-mediated disorder of the central nervous system. The signs of the diseases in most cases are sensory or visual disturbances, weakness in the limbs and symptoms affecting the bladder and bowel. This is followed by either a recovery or an intensification of the symptoms. Fatigue is a symptom, which although not very important medicallyThu, 5 Jan 2012 00:00:00 +0000Strategic Analysis of Healthcare IT Implementation Business Modelshttp://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M59A-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M59A-01-00-00-00
Spiraling healthcare expenditure threatens to reach unsustainable levels on a global scale, which is driving a shift in investment patterns and healthcare business and delivery models. The focus is on better delivery of healthcare and lower costs. Europe is witnessing a rise in the adoption rate of innovative business models such as SaaS, Managed Services, Open Source, and Freemium. The scope of this short issue-based research service is to provide a strategic analysis of the various business models being implemented in the healthcare information technology sector with focus on SaaS, managed services, open source software and the Freemium business models.Wed, 4 Jan 2012 09:16:31 +0000Key Hospital Indicators in GCChttp://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P583-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P583-01-00-00-00
This research service presents an analysis of the key hospital indicators in GCC. It forecasts the key healthcare indicators in the GCC countries from 2006 - 2011 This research service provides in-depth analysis of industry challenges, market drivers and market restraints, and how they impact the market dynamics during the forecast period. It provides a forecast of healthcare infrastructure and manpower needs of the GCC countries. The research also gives an outlook about the Growth Trends in Healthcare in the GCC Countries and Investment Opportunities in Healthcare in The GCC Countries. Sat, 31 Dec 2011 03:37:30 +0000Genetic Technology Alert. Fabric-Based Platform for Rapid Multiplexed Diagnostics; Method for Treating Sickle Cell Anemia Using Patient s Own Cells; Recombinant Fibrinogen as a Therapeutic Tool for Blood and Bone Diseaseshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7C-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7C-00-00
This issue profiles a fabric-based platform for rapid multiplexed diagnostics, a method for treating sickle cell anemia using patient's own cells, and using recombinant fibrinogen as a therapeutic tool for blood and bone diseases. Strategic partnership details and some important patents have also been included.Fri, 30 Dec 2011 05:57:31 +0000Electronic Medical Records--Technology Trends and Stakeholder Assessment (Technical Insights)http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E7-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E7-01-00-00-00
Paper-based records have existed for centuries and their gradual replacement by computerised records has been in practice for sometime now in the western countries. Adoption has varied greatly from country to country. Electronic medical records are the centre of focus of any computerised health information system and without them modern technologies such as decision support systems cannot be effectively integrated with routine clinical workflow. This research service therefore highlights market penetration assessment, technology assessment and benchmarking, stakeholder analysis, patent analysis to name a few.Fri, 30 Dec 2011 02:14:30 +0000Healthcare Expenditurehttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-02-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-02-00-00
Healthcare Expenditure - Decision Support Database focuses on expenditure status of different countries across regions. This database presents fundamental healthcare indicators that aim to explain the wound management capabilities of nations.Thu, 29 Dec 2011 08:26:37 +0000Advances in Stimuli Responsive Polymers--Emerging Application Trends (Technical Insights)http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2DD-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2DD-01-00-00-00
This research service provides a comprehensive overview of the technological advancements in the Stimuli Responsive Polymers. It covers technology capability, technology trends, value-chain analysis, technology adoption cycle, and demand side analysis of the technologies based on Stimuli Responsive Polymers . Further, it focuses on life-cycle analysis, growth opportunity assessment of various technologies in this domain. The study captures industrial and academic innovations of various technologies and products based on Stimuli Responsive Polymers, key drivers and restrains and their impact on different industry verticals. It also provides a list of key patents, key contacts and decision support database tables.Thu, 29 Dec 2011 04:46:31 +0000Strategic Analysis of the European Stem Cell Research Tools Markethttp://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72F-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72F-01-00-00-00
The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research: bio-imaging and microscopy, cell biology tools, immunochemicals, molecular biology tools, and protein biochemistry tools. The study also looks into the usage pattern of these tools. An extensive end-user survey was conducted with 25 laboratories to assess the requirement and usage of tools. Insightful review of key industry drivers, restraints and challenges have been discussed. Leading market players and the prevailing competitive landscape for each of the segments have been discussed.Tue, 27 Dec 2011 07:57:30 +0000Technology Trends and Business Opportunities in the Latin American PACS Market: Brazil, Argentina and Mexicohttp://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N4A5-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N4A5-01-00-00-00
This study covers the technology trends and business opportunities of PACS market for Brazil, Argentina and Mexico, examining the characteristics of the product, drivers and restraints for market growth, industry challenges, pricing, technology trends, demand and installed base. Following from these, market sizing in terms of revenues and units are forecasted, including the future growth rates. In addition, an in-depth analysis of the competitive situation including vendors' market shares is performed, along with profiles of the key players in the industry. The base year is 2009 with forecasts running through 2016.Thu, 22 Dec 2011 10:51:30 +0000Analysis of the U.S. Broadband mHealth Applications Market http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9B6-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9B6-01-00-00-00
This study covers the U.S. Broadband mHealth Market, examining the drivers and restraints, technology, and demand trends. The total market growth is forecasted. In addition, an in-depth analysis of the convergence of this market with telehealth is provided. The base year is 2010, and forecasts are made until 2015. The study reviews downloadable mobile software application sold through a major app store and web-based software application accessed through a mobile device's Internet browser. The study excludes non-dedicated hardware (e.g. cell phones, smartphones, and tablets).Wed, 21 Dec 2011 11:30:30 +0000HEALTHY PEOPLE 2020 AND INNOVATIONS IN HEALTHCAREhttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=249413351
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=249413351
Over the past three decades, the Healthy People Initiative has become the nation's barometer for identifying unmet needs for at risk populations, and setting priorities and 10-year performance objectives to improve the health of all Americans.Wed, 21 Dec 2011 00:00:00 +0000Genetic Technology Alert. Enhancing Translational Research in Cancer through Systems Biology Approaches; Placenta-Derived Stem Cell Therapy for Wide Array of Applications; Adenoviral-Based Gene Therapy for Hemophilia B Shows Promising Resultshttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7B-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7B-00-00
This issue profiles enhancing translational research in cancer through systems biology approaches, a placenta-derived stem cell therapy for a wide array of applications, and an adenoviral-based gene therapy for hemophilia B. Strategic partnership details and some important patents have also been included.Fri, 16 Dec 2011 06:29:30 +0000In Vitro Diagnostics (IVD) in Western Europe: Challenges and Solutionshttp://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=248901213
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=248901213
Thu, 15 Dec 2011 00:00:00 +0000Social Media Use Among the U.S. Healthcare Provider Institutionshttp://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N967-01-00-00-00
http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N967-01-00-00-00
Professional usage of social media (both individual and within institutional frames) is high within healthcare providers institutions. However, only a minority of provider institutions have a dedicated budget for social media. The majority of employees have access to social media in their workplace, but the majority of provider institutions using social media employ some access policies for employee use. Social networking and institutional social media are most often used (among other media), both individually for professional use and for institutional use. Provider institutions appear most interested in using social media for marketing purposes. Social networking and institutions' own social media best fulfill institutions' needs.Mon, 12 Dec 2011 11:21:31 +0000Genetic Technology Alert. Quartz Crystal Microbalance for Small Pox Virus Detection; Antibody-Based Gene Therapy for HIV Infections; Diagnostic Kits Using Blood Samples and Biomarker Testing for Early Disease Detectionhttp://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7A-00-00
http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7A-00-00
This issue profiles applying quartz crystal microbalance for small pox virus detection, an antibody-based gene therapy for HIV infections, diagnostic kits using blood samples and biomarker testing for early disease detection. Strategic partnership details and some important patents have also been included.Fri, 9 Dec 2011 03:57:30 +0000